News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Announces Further Restructuring in R&D; 3,500 More Jobs Eliminated


2/4/2010 7:32:48 AM

Bookmark and Share

Pharmtech -- AstraZeneca (London) announced this week that it plans to undertake further restructuring in its research and development (R&D) operations, resulting in the elimination of 3500 jobs. The move is part of a larger effort by the company to refocus its R&D activities to include a reduction in the number of disease targets within its core therapeutic areas, a continued focus on externalization, and a smaller R&D site footprint.

Read at News Release

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES